285 related articles for article (PubMed ID: 30294259)
1. Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives.
Guo BJ; Yang ZL; Zhang LJ
Front Mol Neurosci; 2018; 11():335. PubMed ID: 30294259
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium Retention after Contrast-Enhanced Magnetic Resonance Imaging: A Narratative Review.
Al-Muhanna AF
Saudi J Med Med Sci; 2022; 10(1):12-18. PubMed ID: 35283709
[TBL] [Abstract][Full Text] [Related]
3. The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.
Olchowy C; Cebulski K; Łasecki M; Chaber R; Olchowy A; Kałwak K; Zaleska-Dorobisz U
PLoS One; 2017; 12(2):e0171704. PubMed ID: 28187173
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.
Stojanov D; Aracki-Trenkic A; Benedeto-Stojanov D
Neuroradiology; 2016 May; 58(5):433-41. PubMed ID: 26873830
[TBL] [Abstract][Full Text] [Related]
5. Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams.
Hu HH; Pokorney A; Towbin RB; Miller JH
Pediatr Radiol; 2016 Oct; 46(11):1590-8. PubMed ID: 27282825
[TBL] [Abstract][Full Text] [Related]
6. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.
Kanda T; Ishii K; Kawaguchi H; Kitajima K; Takenaka D
Radiology; 2014 Mar; 270(3):834-41. PubMed ID: 24475844
[TBL] [Abstract][Full Text] [Related]
7. Gadolinium deposition in the brain.
Kanda T; Nakai Y; Oba H; Toyoda K; Kitajima K; Furui S
Magn Reson Imaging; 2016 Dec; 34(10):1346-1350. PubMed ID: 27613998
[TBL] [Abstract][Full Text] [Related]
8. Extent of Signal Hyperintensity on Unenhanced T1-weighted Brain MR Images after More than 35 Administrations of Linear Gadolinium-based Contrast Agents.
Zhang Y; Cao Y; Shih GL; Hecht EM; Prince MR
Radiology; 2017 Feb; 282(2):516-525. PubMed ID: 27513848
[TBL] [Abstract][Full Text] [Related]
9. High signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification.
Barbieri S; Schroeder C; Froehlich JM; Pasch A; Thoeny HC
Contrast Media Mol Imaging; 2016 May; 11(3):245-50. PubMed ID: 26929131
[TBL] [Abstract][Full Text] [Related]
10. Hyperintensity in the Dentate Nucleus on Nonenhanced T1-Weighted Magnetic Resonance Imaging Suggests Dechelation of Contrast Agents.
Jessome R
J Med Imaging Radiat Sci; 2016 Mar; 47(1):86-91. PubMed ID: 31047168
[TBL] [Abstract][Full Text] [Related]
11. High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted MR Images: Comparison between Gadobutrol and Linear Gadolinium-Based Contrast Agents.
Moser FG; Watterson CT; Weiss S; Austin M; Mirocha J; Prasad R; Wang J
AJNR Am J Neuroradiol; 2018 Mar; 39(3):421-426. PubMed ID: 29419400
[TBL] [Abstract][Full Text] [Related]
12. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
Stojanov DA; Aracki-Trenkic A; Vojinovic S; Benedeto-Stojanov D; Ljubisavljevic S
Eur Radiol; 2016 Mar; 26(3):807-15. PubMed ID: 26105022
[TBL] [Abstract][Full Text] [Related]
13. Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement.
Quattrocchi CC; Ramalho J; van der Molen AJ; Rovira À; Radbruch A;
Eur Radiol; 2019 Aug; 29(8):3959-3967. PubMed ID: 30413951
[TBL] [Abstract][Full Text] [Related]
14. Pediatric Brain: Gadolinium Deposition in Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images Is Dependent on the Type of Contrast Agent.
Ryu YJ; Choi YH; Cheon JE; Lee WJ; Park S; Park JE; Kim WS; Kim IO
Invest Radiol; 2018 Apr; 53(4):246-255. PubMed ID: 29300210
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium Deposition in Neurology Clinical Practice.
Smith TE; Steven A; Bagert BA
Ochsner J; 2019; 19(1):17-25. PubMed ID: 30983897
[No Abstract] [Full Text] [Related]
16. Brain gadolinium deposition after administration of gadolinium-based contrast agents.
Kanda T; Oba H; Toyoda K; Kitajima K; Furui S
Jpn J Radiol; 2016 Jan; 34(1):3-9. PubMed ID: 26608061
[TBL] [Abstract][Full Text] [Related]
17. Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent.
Barisano G; Bigjahan B; Metting S; Cen S; Amezcua L; Lerner A; Toga AW; Law M
AJNR Am J Neuroradiol; 2019 Aug; 40(8):1274-1281. PubMed ID: 31345942
[TBL] [Abstract][Full Text] [Related]
18. Are some agents less likely to deposit gadolinium in the brain?
Radbruch A
Magn Reson Imaging; 2016 Dec; 34(10):1351-1354. PubMed ID: 27629022
[TBL] [Abstract][Full Text] [Related]
19. Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast.
Roberts DR; Holden KR
Brain Dev; 2016 Mar; 38(3):331-6. PubMed ID: 26345358
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium Deposition in Deep Brain Structures: Relationship with Dose and Ionization of Linear Gadolinium-Based Contrast Agents.
Kang H; Hii M; Le M; Tam R; Riddehough A; Traboulsee A; Kolind S; Freedman MS; Li DKB
AJNR Am J Neuroradiol; 2018 Sep; 39(9):1597-1603. PubMed ID: 30139752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]